当前位置：首页 > 文献互助 > 互助详情

Futibatinib after non-covalent FGFR inhibitors in FGFR2-rearranged intrahepatic cholangiocarcinoma: clinical activity and resistance patterns复制

用户odusrbT5lLew 39分钟前 13 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-09-30 20:42:51 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: DOI: 10.1016/j.ejca.2026.117036复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0959804926008178复制

其他信息:

出版社: Elsevier BV
作者: Simona Casalino; Enza Scarlato; Marina Crespo Cruz; Christoph Gerdes; Anna Sordo; Alberto Quinzii; Camilla Zecchetto; Luisa Messineo; Ester Tasselli; Lucia Mendo; Anna Saborowski; John Bridgewater; Arndt Vogel; Davide Melisi

上一篇：Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

下一篇：Integrative multi-omics identifies cholangiolocarcinoma as a distinct molecular subtype of intrahepatic cholangiocarcinoma

互助时间线

2026-09-23 20:45:12 [完结求助]

楼主确认了小小书虫应助的文件是正确的, 求助状态变成 已完结

2026-09-23 20:42:51 [上传文件]

小小书虫上传了文件(pdf 2.39 MB), 求助状态变成 待确认

2026-09-23 20:40:13 [发起求助]

最新发布的求助

卓國雄、盧俊宏（2005）。中文版表現失敗評估量表之修訂研究：探索性和驗證性因素分析。大專體育學刊，7(2)，111-123。 4分钟前
Extending the Treatment Window for Intravenous Thrombolysis in Acute Ischemic Stroke 16分钟前
Multiomics Integration Identifies a Molecular Subtype of Intrahepatic Cholangiocarcinoma With Enhanced Benefit From Adjuvant Therapy 32分钟前
Multiomics Integration Identifies a Molecular Subtype of Intrahepatic Cholangiocarcinoma With Enhanced Benefit From Adjuvant Therapy 33分钟前
Integrative multi-omics identifies cholangiolocarcinoma as a distinct molecular subtype of intrahepatic cholangiocarcinoma 37分钟前
Futibatinib after non-covalent FGFR inhibitors in FGFR2-rearranged intrahepatic cholangiocarcinoma: clinical activity and resistance patterns 39分钟前
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study 46分钟前
Tegileridine vs . sufentanil for postoperative analgesia in general surgery: A prospective, randomized, controlled, non‐inferiority trial. 48分钟前
Convergence of Local and Systemic Therapies: A Comprehensive Society of Interventional Oncology Framework for 90 Y Radioembolization with Immunotherapy in HCC 51分钟前
Clinical outcomes of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and anti‐PD‐1 immunotherapy for unresectable intrahepatic cholangiocarcinoma 58分钟前
Hepatic Artery Infusion Chemotherapy as a First‐Line Treatment in Unresectable Cholangiocarcinoma: A Systematic Review and Meta‐Analysis 1小时前
FOLFOX-HAIC versus first-line systemic chemotherapy in HBsAg-positive patients with unresectable intrahepatic cholangiocarcinoma: A propensity score matched cohort study 2小时前

wispass工作室 Copyright © 蜀ICP备20005939号-4 www.wispass.com